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Introduction: An estimated 242 million people in the world are living with symptomatic and 
activity-limiting osteoarthritis (OA). Women are 2-6X more likely to experience musculoskeletal 
injury and degeneration, highlighting a sexual dimorphism in diseases such as OA. One major 
cause of knee osteoarthritis is damage or injury to the fibrocartilaginous meniscal discs. The most 
common treatment for meniscal injury is partial or complete resection of the meniscus by 
meniscectomy. With resection of the meniscal tissue, the meniscus structural benefits to the joint 
are severely limited.  Estrogens are steroid hormones that function to promote gene transcription 
and downstream activity and to play a role in musculoskeletal cell proliferation and new 
extracellular matrix production. The overall purpose of this thesis is to develop models for 
understanding the in-vitro response of meniscal cells to estrogen treatment to both determine a 
mechanism for the sex differences in OA and identify therapeutic strategies to promote new 
meniscal tissue growth by capitalizing on estrogen signaling. 
Methods: Meniscus cells were harvested from the lateral, and medial meniscal discs of bovine 
(17 months old) and human samples (male and female, 18 years and 47 years old) and separated 
based on region (inner vs outer). The effect of hormone-free media composition, estrogen dosing 
concentration and kinetics, and 2D vs  3D on cell proliferation and extracellular matrix production 
was determined using assays to assess cell number and quantify RNA and protein level changes 
to extracellular matrix components. Specifically, the effect of hormone-free media components, 
namely charcoal/dextran treated FBS (Char FBS) and phenol red-free basal media (prfDMEM), 
on cell proliferation and ECM production was assessed to establish baseline readings prior to 
estrogen studies. Estrogen dosing at low and high doses and pulsed or continuous dosing kinetics 
was completed. Lastly, scaffold-free spheroid culture models were established using a hanging 
drop method to assess the role of estrogen in 3D. 
Results: Both 2D and 3D in-vitro models were established in hormone-free culture media for 
estrogen dosing studies. Proliferation at day one in both 10 % and 15 % Char FBS was not 
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statistically different from the control group. No statistically significant changes to total GAG and 
collagen content were observed due to media composition or estrogen treatment. Phenol red-free 
DMEM (prfDMEM) significantly reduced cell proliferation compared to cells in charcoal FBS and 
normal FBS medium. Estrogen treatment showed no observable differences between conditions 
at 24 and 72 hours from inner and outer meniscus in cell proliferation. Gene expression of 
extracellular matrix components showed preliminary evidence that estradiol exhibited dose-
dependent effects in both male and female cells. There are significant differences between sexes 
in cell proliferation but not significant differences in gene expression of matrix macromolecules.  
Conclusions: 2D and 3D culture models were established to assess the role of estrogen on 
bovine and human MFCs. Using these models, it was determined that E2 promotes the 
upregulation of ACAN and Col2a1 gene expression while decreasing Col1a1 expression, at 
concentrations of 10-8M. Further, in the spheroid culture model, 10-8M E2 decreased significantly 
less in diameter compared to the 0M E2 group. Overall, these results highlight that MFCs, 
although partly responsive, are likely not the cell type responsible for responding to estrogen 
treatment at these dosages and culture conditions. The models developed in this thesis will 
continue to be explored to expand our working knowledge and develop better strategies to probe 
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An estimated 242 million people in the world are living with symptomatic and activity-limiting 
osteoarthritis (OA). Within this population, an estimated 31 million people suffer from OA in the 
US. Women are 2-6X more likely to experience musculoskeletal injury and degeneration(Felson 
& Nevitt, 1998), highlighting a sexual dimorphism in diseases such as OA. One major cause of 
knee osteoarthritis is damage or injury to the fibrocartilaginous meniscal discs. Recently, two 
meta-analysis studies (>1,000 meniscus injuries analyzed) have indicated that sex plays a role in 
meniscal injury and repair. First, meniscal injury rates are higher for female high school athletes 
compared to males comparing data from gender-comparable sports(Mitchell et al., 2016). 
Second, data analysis has shown that females required repeat surgeries 2.2X more frequently 
than males after initial meniscal repair(Patel, Mundluru, Beck, & Ganley, 2019). These differences 
point towards meniscal repair rates dependence on sex hormones, namely estrogen. 
Understanding the role of estrogen on meniscus health is necessary to both determine a potential 
 
 





role in osteoarthritis and develop a regenerative strategy to provide tissue homeostasis and 
reduce the onset of OA. 
1.1. The meniscus 
The meniscus of the knee has two semi-lunar fibrocartilaginous discs as seen in Figure 1. The 
lateral and medial meniscus are wedged between knee joint and, in contrast to other cartilaginous 
disks, only cover part of the joint surface. The knee meniscus contributes significantly to the 
biomechanical function of the joint and functions to stabilize, distribute forces in the joint, and act 
as a shock absorber(Makris, Hadidi, & Athanasiou, 2011). The meniscal discs are composed of 
a tridimensional complex of primarily collagen, water, and proteoglycans(Maffulli, Longo, Campi, 
& Denaro, 2010).The meniscus has two distinct regions, the avascular (inner 1/3rd) and the 
vascular region (outer 2/3rd)(Maffulli et al., 2010; Makris et al., 2011) The vascularized zone of the 
meniscus is divided into the red-red, and the red-white zones as seen in Figure 2. The meniscal 
zones have distinct cell phenotypes. The outer vascularized zone contains cells with spindle-
shaped, fibroblast morphology while the inner, avascular zone has cells with round, chondrocyte 
morphologies. Figure 3 illustrates the meniscus cellular and extracellular matrix composition. The 
primary regional differences present in the tissue include collagen composition, collagen fiber 
alignment and their organization, and proteoglycans content. At the surface, the fibers are aligned 
 
Figure 2 Meniscus graphical representation of vascularity. Outer meniscus (red-red) and middle region 






randomly, while the bulk of the tissue has circumferential and radial aligned fibers(Aspden, 
Yarker, & Hukins, 1985). Each region is made of fibers that are separated into multiple layers and 
 
Figure 3 Illustration of the cellular composition of the meniscus. The meniscus has a heterogeneous 
cell composition but there are regional differences as seen in the illustration. Recently it has been 
postulated that a small number of progenitor like cells are present in the surface of the meniscus. Inner 
meniscus is primarily composed of chondrocyte like fibrochondrocytes while the outer region is primarily 






Figure 4 Synoptic drawing. Scanning electron microscopy reveals three distinct layers in the meniscus 
cross section: (1) The superficial network: the tibial and femoral sides of the meniscus surface are 
covered by a meshwork of thin fibrils. (2) Lamellar layer: beneath the superficial network there is a layer 
of lamellae of collagen fibrils on the tibial and femoral surface. In the area of the external circumference 
of the anterior and posterior segments the bundles of collagen fibrils are arranged in a radial direction. 
In all other parts the collagen fibril bundles intersect at various angles. (3) Central main layer: the main 
portion of the meniscus collagen fibrils is located in the central region between the femoral and the tibial 
surface layers. Everywhere in the central main layer of the meniscus the bundles of collagen fibrils are 
orientated in a circular manner. In the region of the internal circumference a few radial collagen fibrils 
are interwoven with the circular fibril bundles (arrowheads). In the external circumference loose 
connective tissue from the joint capsule penetrates radially between the circular fibril bundles 







multiple orientations, which gives the tissue its impressive mechanical properties. Figure 4 
(Petersen & Tillmann, 1998)shows the orientation of these fibers. The circumferential orientation 
allows the dissipation of compressive forces through hoop stresses. Without the circumferential 
fibers, the meniscus would be extruded out of the joint. The radial fibers provide structural support 
by forming tie-ins to the circumferential fibers. They also dissipate the forces that could lead to 
longitudinal splitting in the meniscus. The tensile modulus of the meniscus in the circumferential 
fiber region is in the range of 100-300 MPa, while at the radial fibers is ten times lower(Makris et 
al., 2011) The shear modulus of the tissue is in the range of 120kPa(Makris et al., 2011).  
1.2. The extracellular matrix 
The extracellular matrix (ECM) is composed of a complex, interlocking fibrous proteins and 
glycosaminoglycans supporting cells. Of these proteins, collagen is the number one constituent 
of the ECM, making up roughly 75%(Herwig, Egner, & Buddecke, 1984; Proctor, Schmidt, 
Whipple, Kelly, & Mow, 1989). The meniscus ECM is composed primarily of collagen type 
1(Abraham & Donahue, 2013; Aspden et al., 1985; Makris et al., 2011) but an assortment of other 
types of collagen variants are present in the tissue. Other important components of meniscus 
ECM are proteoglycans, which make up about 17% of the total organic matter of the 
meniscus(Herwig et al., 1984; Proctor et al., 1989); aggrecan is the major large proteoglycan in 
this matrix(Scott, Nakano, & Dodd, 1997). Proteins such as fibronectin and collagen VI serve as 
a link between ECM and meniscus cells. 
When considering the environment for cells one should consider the hierarchical composition of 
tissues. The ECM is composed of multiple layers that range from fibers in the micro scale to whole 
tissues at the macro scale. The ECM anchors cells within its fibrillar proteins and polysaccharides 
to provide a specific environment providing structural support and cell adhesion. The ECM and 
cells feed each other signals, where the forces generated by the ECM are equivalent to the level 
of tension provided by the cytoskeleton in the cells(Bao, Xie, & Huck, 2018). The ECM sequesters 
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proteins and peptides via charge as well and thus provides mechanical and chemical cues to the 
cells. The extracellular matrix can be composed of different materials depending on the tissue or 
organ in question. Due to the feedback between cells and substrate, one should consider not only 
materials, but also overall properties that have an effect on the cells when designing regenerative 
strategies for the meniscus. 
1.3. Clinical need of meniscus regeneration 
Meniscal injuries occur at the rate of 1 million cases every year in the US alone. It has been 
reported that the incidence of meniscal injury resulting in meniscectomy is 61 per 100,000, of 
which medial versus lateral meniscus injury was 81 versus 19%, respectively(B. E. Baker, 
Peckham, Pupparo, & Sanborn, 1985). The vast majority of these surgeries include the resection 
of the meniscal tissue, taking away the structural benefits of the tissue and its function from the 
area. This used to be the gold standard in the treatment of meniscal tears(Abraham & Donahue, 
2013; Butler, Juncosa, & Dressler, 2004; Maffulli et al., 2010; Makris et al., 2011) up until 
recently(Gillquist, Hamberg, & Lysholm, 1982). This procedure leads to the degradation of the 
cartilaginous tissue and potential development of osteoarthritis. With the recent understanding of 
 
Figure 5 Common meniscal tear types. (A) horizontal, (B) radial, (C) vertical, (D) flap, (E) parrot beak, 






meniscus properties and role in joint health, partial meniscectomy is now the standard of care for 
meniscus tears that cannot be sutured or repaired. Meniscal injury patterns are shown in Figure 
5. The types of tears that can occur are 5A horizontal, 5B radial, 5C vertical, 5D flap, 5E parrot 
beak, and 5F bucket handle. These injuries can be combinatorial or just one depending on the 
severity of the injury. Overall, the type of tear and subsequent lack of meniscus repair is 
associated with OA development(Jarraya et al., 2017). The reconstruction of these injuries is 
primarily done by replacing the injured site with an autogenous or allogeneous soft tissue. The 
problem that arises from this approach is that these do not remodel as the previous attachment 
site(Abraham & Donahue, 2013; Apostolakos et al., 2014; Deymier et al., 2017), as well as there 
being limited resources due to the lack of cadaveric allografts that make up the majority of the 
repairs. Meniscal repair in the avascular zone with most surgical procedures give mixed results 
as to the efficacy of treatment(Dutton, Choong, Goh, Lee, & Hui, 2010). Even in the vascularized 
zone of the meniscus, re-rupture of the tissue occurs at a rate of 30%(Gillquist et al., 1982).  
1.4. Male vs female dimorphism in other tissues 
Estrogens are steroid hormones that function to promote gene transcription and downstream 
activity. Estrogens bind with a high affinity to estrogen receptors alpha (ERα) and beta (ERβ). 
These receptors have been shown to be present within several cell types including meniscal 
fibrochondrocytes (W. Wang, Hayami, & Kapila, 2009) . Estrogen has been shown to regulate 
differentiation of mesenchymal stem cells into osteoblast and osteoclast(Almeida et al., 2016) . 
Similarly, growth plate chondrocytes exhibit sex specific response to  treatment(Elbaradie, Wang, 
Boyan, & Schwartz, 2013).The differences in response to estrogen treatment could be due to the 
receptors associated with the stimulus as intracellular receptors and membrane associated 
receptors have been shown to produce a different response in chondrocytes (Dienstknecht, 
2010). 
1.5. Dosing kinetics 
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Estrogen affects transcriptional status by activating its corresponding nuclear receptor, it is also 
understood that it can elicit cellular reactions within minutes that do not conform to the 
transcription mediated effects of estrogen(Azuma & Inoue, 2012). These reactions are considered 
“non-genomic”.  The classical pathway of transcription results in estrogen binding to the ERα or 
ERβ which then elicits a series of changes including conformational change, dimerization, and 
translocation to the nucleus(Beato, Herrlich, & Schütz, 1995). The receptor complex will then 
bind to the estrogen response element and act as an enhancer attracting co-factors and to 
promote gene transcription(Carroll et al., 2006; Klinge, 2001). The biological effects of estrogen 
are the result of a complex interplay of transcriptional and non- transcriptional signaling 
mechanisms. A report by Simoncini et al. showed that the effect of dosing kinetics produces 
 
Figure 6 Schematic Illustration of ER Signaling Mechanisms 1. Classical mechanism of ER action. 
Nuclear E2-ERs bind directly to EREs in target gene promoters. 2. ERE-independent genomic actions. 
Nuclear E2-ER complexes are tethered through protein-protein interactions to a transcription factor 
complex (TF) that contacts the target gene promoter. 3. Ligand-independent genomic actions. Growth 
factors (GF) activate protein-kinase cascades, leading to phosphorylation (P) and activation of nuclear 
ERs at EREs. 4. Non-genomic actions. Membrane E2-ER complexes activate protein-kinase cascades, 
leading to altered functions of proteins in the cytoplasm, e.g. activation of eNOS, or to regulation of gene 







different responses from human umbilical vein endothelial cells(Simoncini et al., 2005). The effect 
seen was that the estrogen administered in a pulsed treatment elicited a non-genomic response 
in which the response elicited was quick after contact with the estrogen and the receptor. This 
study expanded on previous research that demonstrated that the dosing kinetics produce a similar 
effect on a mouse animal model(Devissaguet, Brion, Lhote, & Deloffre, 1999) as well as normal 
and cancer cell lines in proliferation(Cavaillès et al., 2002). In another study it was shown that the 
dosage administration of estrogen caused gene expression differences between pulsed and 
continuous treatments and had a significant increase in apoptosis and proliferation related cell 
cycle pathways(Li et al., 2008). Estrogen and its release kinetics can then be hypothesized to 
produce a response in regards to administration and dosage. The current understanding of the 
events caused by estrogen are summarized in Figure 6(Björnström & Sjöberg, 2005). In a recent 
study using an ovariectomized rat model, estradiol was administered at a pulse or continuous 
treatment; in this study, they analyzed the effects of this treatment in the bone, uterus, liver and 
mammary glands of the rats. In its results the researchers demonstrated that the pulsed release 
had a significantly reduced incidence of stimulatory effects of estrogen(Otto et al., 2012). The 
effects of E2 treatment in a pulsed treatment was seen to successfully prevent ovariectomized 
induced bone loss(Otto et al., 2012). This method of administration can be exploited when treating 
different conditions where local delivery at a control rate is desired to reduce the risk of estradiol’s 
negative effects as a systemic treatment.  
The overall purpose of this thesis was to develop models for understanding the in vitro response 
of meniscal cells to estrogen treatment to both determine a mechanism for the sex differences in 
OA and identify therapeutic strategies with estrogen. The overall hypothesis was that estrogen 
treatment would promote proliferation of cells and ECM protein upregulation at 17β-estradiol (E2) 
treatment conditions. In the context of the overall hypothesis, three specific hypotheses were 
tested. First, it was hypothesized that a hormone-free media composition would be determined to 
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produce the same or higher proliferation of cells. In the following study, it was hypothesized that 
estrogen treatment would increase proliferation and gene expression of extracellular matrix 
(ECM) proteins. Lastly, it was hypothesized that dosage kinetics would not produce an increase 
in proliferation but that estrogen dosage would. Also understanding the appropriate dosage to 
elicit an appropriate response to provide the local population of cells the adequate cues for 
homeostasis is vital. The studies presented in this thesis aimed to determine the role of estrogen 
on bovine and human primary meniscal fibrochondrocyte proliferation and extracellular matrix 
production as a function of age, sex, and region. Techniques were used to determine changes in 
cell phenotype at the RNA and protein level to get an overall picture of the cells’ response to 
estrogen treatment. 
2. Materials 
Media and solutions for cell culture 
Table 1 Media composition for cell culture experiments 
Solution Composition 
Live dead solution 2uM Calcein 
4uM ethidium homodimer-1 
PBS 
Freezing Cell Media 10% (v/v) DMSO 
90% (v/v) FBS 




10% Char FBS Culture Media 88% DMEM Phenol Red (-) 
10% Char FBS 
1% Pen-strep 
1% L-Glutamine 
15% Char FBS Culture Media 83% DMEM Phenol Red (-) 
15% Char FBS 
1% Pen-strep 
1% L-Glutamine 
10-6M E2 Culture Media 83% DMEM Phenol Red (-) 




10-8M E2 Culture Media 83% DMEM Phenol Red (-) 







10-9M E2 Culture Media 83% DMEM Phenol Red (-) 




24*10-8M E2 Culture Media 83% DMEM Phenol Red (-) 




24*10-9M E2 Culture Media 83% DMEM Phenol Red (-) 




10ng/ml TGFB3 83% DMEM Phenol Red (-) 




Table 2 Primers for gene expression 
Gene   Species Gene ID Lot# Provider 
Gapdh Bovine Bt03210913_g1 P180522-016 D06 Life Technologies 
Col1a1 Bovine Bt1463861_g1 1700337 Life Technologies 
Col2a1 Bovine Bt03251861_m1 P180522-016 D08 Life Technologies 
Col1a2 Bovine Bt03214860_m1 P180522-016 D07 Life Technologies 
ACAN Bovine Bt03212186_m1 P180522-016 D09 Life Technologies 
Gapdh Human Hs99999905_m1 1688723 Life Technologies 
Col1a1 Human Hs00164004_m1 1717939 A7 Life Technologies 
Col2a1 Human Hs0500163_m1 P180927-011 B03 Life Technologies 
Col1a2 Human Hs0016099_m1 1690104 A5 Life Technologies 
GPER Human Hs00173506_m1 1602319 A7 Life Technologies 
ESR1 Human Hs01046812_m1 1504917 F9 Life Technologies 
ESR2 Human Hs01100353_m1 1729637 E5 Life Technologies 
ACAN Human Hs00153936_m1 1717962 A9 Life Technologies 
 
Table 3 List of biological material 
Species Sex Tissue Age Use 
Bovine  Male Meniscus 17 months Media Composition Study 
Bovine  Male Meniscus 17 months Estrogen Study 
Bovine  Female Meniscus Unknown Estrogen Study 
Human Male Meniscus 47 years Dosage Kinetics Study 
Human Female Meniscus 47 years Dosage Kinetics Study 




Table 4 Experimental groups for media composition study 
Subject 






Male Bovine 10% FBS 5 1, 3, 7 Inner Meniscus 
Male Bovine 10% Char FBS 5 1, 3, 7 Inner Meniscus 
Male Bovine 15% Char FBS 5 1, 3, 7 Inner Meniscus 
Male Bovine 10% FBS 5 1, 3, 7 Outer Meniscus 
Male Bovine 10% Char FBS 5 1, 3, 7 Outer Meniscus 
Male Bovine 15% Char FBS 5 1, 3, 7 Outer Meniscus 
 
 
Table 5 Experimental groups for pulsed versus continuous study 
Group Treatment Meniscus  Time points (days) 
Control 0 E2 Lateral Meniscus 1, 3, 7 
High Pulsed  24e10-8 E2 Lateral Meniscus 1, 3, 7 
High Continuous  10-8 E2 Lateral Meniscus 1, 3, 7 
Low Pulsed 24e 10-9 E2 Lateral Meniscus 1, 3, 7 
Low Continuous 10-9 E2 Lateral Meniscus 1, 3, 7 
Control 0 E2 Medial Meniscus 1, 3, 7 
High Pulsed  24e10-8 E2 Medial Meniscus 1, 3, 7 
High Continuous  10-8 E2 Medial Meniscus 1, 3, 7 
Low Pulsed 24e 10-9 E2 Medial Meniscus 1, 3, 7 
Low Continuous 10-9 E2 Medial Meniscus 1, 3, 7 
 
Table 6 Experimental groups for regional separation study 
 
3.1. Tissue harvest 
Group Treatment Meniscus Region Time points (days) 
Control 0 E2 Inner 1, 7 
Pulsed E2 24e10-8 E2 Inner 1, 7 
Continuous E2 10-8 E2 Inner 1, 7 
Control 0 E2 Middle 1, 7 
Pulsed E2 24e10-8 E2 Middle 1, 7 
Continuous E2 10-8 E2 Middle 1, 7 
Control 0 E2 Outer 1, 7 
Pulsed E2 24e10-8 E2 Outer 1, 7 
Continuous E2 10-8 E2 Outer 1, 7 
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Stifle joints from a steer were procured from a local butcher shop (Bichelmeyer Meats, Kansas 
City). The animals were estimated to be 17 months old, the joints procured for this study were 
both male. The steer was sacrificed days prior to collecting the joints, the joints were kept under 
refrigerated condition but not frozen. Once retrieved the knees were sterilized by submerging in 
a 1% weight/volume(wt/v) solution of Alconox detergent (Fisher Scientific, Lot#A4G2) for 40 
minutes, and subsequently submerged for 20 minutes in a 70% Ethanol (Fisher Scientific 
Lot#175343) solution for 20 minutes. Tissue extraction was performed in a sterile biosafety 
cabinet. The biosafety cabinet was first scrubbed with a Clorox solution followed with a 70% 
ethanol solution, and then it was lined with absorbent padding to prevent fluids to be exposed to 
the surface. The padding was sterilized by turning on the UV light for 10 minutes on each side of 
the padding. 
The bovine joint was introduced into the biosafety cabinet for dissection and opening of the 
capsule as seen in Figure 7. Removal of soft tissues and other ligament attachments for ease of 
access to the joint was performed. Discarded tissues were stored in biosafety bags and frozen 
for disposal through incineration as per the University of Kansas Animal Care Unit instructions. 
Once the menisci were excised from the joint, they were stored in sterile PBS to maintain them 
hydrated on 150 mm* 25 mm poly(styrene) petri dishes (Corning). A fine dissection was 
performed to remove excess soft and connective tissues based on previous methods 
 







(Subramony, Su, Yeager, & Lu, 2014). The meniscus was separated into outer and inner regions 
with the mid white-red region being stored for other studies. The meniscus once separated into 
outer and inner regions were then chopped into 1-2 mm pieces. The meniscus tissue was then 
placed in pre-measured 50 ml conical tubes in 10 ml of PBS to maintain the tissues hydrated. 
Once the mincing process was completed the PBS was aspirated and the mass of the tissue was 
calculated to determine the appropriate concentration of collagenase media to produce. 
Collagenase media was prepared at a 1.5mg/ml concentration approximately following previous 
protocols. The minced tissues were stored in an incubator with the collagenase solution at 37 
degrees Celsius (°C) and 95% humidity in an orbital shaker (Corning LSE) set at 2400 RPM for 
16 hours. Digested tissue supernatant was removed and placed in fresh 50ml conical tubes; the 
tubes were then spun at 400G for 10 minutes to pellet the cells. The pellet was suspended in 20 
ml of media and cells were plated separating medial and lateral meniscus. The cells were cultured 
to 90% confluency and passaged. Cell imaging was performed using an inverted light microscope 
(Zeiss inverted microscope) the images were collected at different passages using a 10X 
objective under bright field microscopy.  
3.2. Live Dead Assay 
Live/Dead assay (Invitrogen, L3224, Life Technologies) was performed as recommended by the 
manufacturer. To ensure the difference in media composition did not affect the cells viability (n=5). 
Briefly samples were cultured with the media compositions in the experiment for 24 hours and 
then the samples were rinsed with phosphate buffered saline (PBS; Sigma Aldrich), stained, and 
then imaged using a plate reader (Cytation 3, BioTek Instruments) using a 4X objective.  
3.3. Growth Kinetics 
In order to characterize the normal growth rate and behavior of the cells two ten day growth 
studies were performed. In the first growth study ten time points every 24 hours for ten days were 
taken of five replicates of healthy outer MFC’s at passage three derived from an 18-year-old 
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deidentified male. In the second growth study, eight replicates of three different tissue culture 
media containing varying concentrations of phenol red were tested to determine what the effect 
of phenol red concentration is on mid MFCs at passage two and increase confidence in future 
results. Outer MFCs were thawed and were seeded at an initial density of 104 cells/mL in T75 
flasks at their second passage. Once the cells reach confluency, cells were then seeded in 6-well 
plates at a density of 104 cells/cm2 in premium DMEM (10% FBS) at passage three. They will then 
were allowed to culture for 24 hours after which the DMEM was replaced with phenol red-free 
DMEM. The cells were cultured in the phenol red-free medium for 24 hours prior to treatment. 
Phenol red free DMEM was used because it has been found that phenol red mimics nonsteroidal 
estrogen and will bind to estrogen receptors of estrogen sensitive cells. Phenol red free DMEM 
was used to incubate the cells 24 hours prior to study to make the cells naïve to any possible 
sources of estrogen and estrogen mimetic compounds. 
Ten time points at passage three were seeded at a density of 10,000 cells/cm2 in 6-well plates. 
The cells were allowed to grow until their collection time, which occurred every 24 hours from day 
one to day ten. Triton-X 100 at 0.1% v/v was added to each sample at the time of collection in 
order to lyse open the cell membrane to allow access to the nucleic acid for further data 
acquisition. After collection, the lysate samples were frozen at -20°Cuntil they were analyzed. Ten 
time points at passage two were seeded at a density of 10,000 cells/ mL in 48-well plates. The 
cells were separated into groups and were exposed to one of the three different types of media 
listed under Figure 10, which would represent exposure to different concentrations of various 
different estrogen mimetic compounds present in tissue culture media. The cells were collected 
every 24 hours from day one to day ten.  
3.4. Cell proliferation 
Initial seeding density for the study was 5000 cells/cm2. Cell proliferation was determined by 
measuring total DNA content per sample using the Quant it ds DNA PicoGreen assay (p7589, 
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Life Technologies) this according to the manufacturer’s suggested protocol. The samples in 
culture were rinsed using phosphate buffered saline and the cells were then lysed with 300uL of 
0.1% Triton X-100 solution (Sigma, T8787). The cell lysates were stored at -20°C until the assay 
was performed. At the time of running the assay, an aliquot of 20ul was then added to the working 
solution of the PicoGreen assay. The fluorescence was measured with a microplate reader 
(Cytation5, BioTek Instruments) with wavelengths of 485nm and 535nm for excitation and 
emission respectively. The total cell number was determined by converting the total amount of 
DNA per sample to cell number using the conversion factor of 7.7 pg DNA/cell (Kim, Sah, Doong, 
& Grodzinsky, 1988) following previously established protocols(Jiang, Leong, Mung, Hidaka, & 
Lu, 2008). 
3.5. Biochemical Analysis 
Total collagen and GAG content per sample was measured by executing Hydroxyproline assay 
and DMMB assay respectively. These assays were performed after 16 hours of papain digestion 
(Sigma-Aldrich) to solubilize the cellular material in suspension. Acetate citrate buffer was 
prepared by diluting the following reagents into 250 ml of distilled water 60g of sodium acetate 
trihydrate (Sigma-Aldrich, S-7670), 23g of citric acid (Sigma-Aldrich, C-1909), 6mL acetic acid 
(Fisher, BP2401), 17g of NaOH (Sigma-Aldrich, S-5881). The solution was set for 30 minutes in 
a magnetic stirrer and monitored until complete dissolution of the reagents was observed. Once 
this was completed, the solution was brought to PH of 6.5 using either 1M NaOH. Once adjusted 
the solution was brought up to a final volume of 500mL. 0.056M Chloramine T solution was 
prepared the day the assay was performed. First in 20mL 50% reagent grade isopropanol 1.27g 
Chloramine T (Sigma-Aldrich, 857319) was dissolved, this was then brought to 100mL with 
Acetate-Citrate buffer. Ehrlich’s Reagent was prepared 1n 100mL (2:1 v/v) isopropanol (reagent 
grade): perchloric acid (Sigma-Aldrich, 244252) (66.7mL isopropanol, 33.3mL perchloric acid) to 
which it was added 15g of p-dimethylaminobenzaldehyde (Sigma-Aldrich, 156477). Samples 
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were concentrated in a vacuum oven from the digestion lysate overnight. The sample was then 
hydrolyzed using 25ul of 2M NaOH and autoclaving the samples for 25 minutes. Then the samples 
were prepared in 2ml Eppendorf tubes by adding 225ul of the chloramine T into 25ul of the 
hydrolysate. The oxidation reaction was allowed to run for 25 minutes at room temperature. 250ul 
Ehrlich reagent was added to each sample and allowed to incubate at 65 C for 20 minutes.  Once 
the reaction was complete the samples were thoroughly mixed using a vortex mixer and 200ul of 
the sample was plated into a 96 well plate. Absorbance was measured using Cytation 5 microplate 
reader at 555nm wavelength. A standard curve was prepared to correlate the content of collagen 
based on absorbance(DasGupta, 1970; Reddy & Enwemeka, 1996; Subramony et al., 2014) . 
The concentrations of the standard curve are summarized in Table 7. 
Table 7 Standard Curve values for Hydroxyproline Assay 
 1 2 3 4 5 6 7 
Collagen (mg/ml) 0.001 0.005 0.01 0.05 0.1 0.5 1 
 
Total GAG content per sample was measured by performing DMMB assay. Reagents were 
prepared ahead of time DMMB dye was prepared by dissolving 0.4 grams of sodium formate into 
160 ml of distilled water. In a separate 15 ml conical tube, 4.2mg of 1-9-dimethylmethylene blue 
was dissolved into 1 ml ethanol. Formic acid was used to bring the pH to 1.5. Once adjusted the 
volume was brought to 200ml and stored in the fridge covering the container with foil to prevent 
light interaction with the Dye. A standard curve was prepared to correlate the GAG content based 
on the absorbance of the assay the concentrations of said standard are summarized in Table 8. 
Using a working solution of 50μg/ml following the volumes in the table below. Once the samples 
were digested, they were allowed to return to room temperature before preparing the plate. 50μl 
of the sample was plated after the tubes were thoroughly mixed by using a vortex mixer. 250μl of 
dye was added quickly to the sample as the GAG complexes will precipitate and become 
unreadable in a very short period of time. Preparation of the assay was done in dim light to 
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mitigate light exposure from affecting our absorbance readings. Absorbance was measured using 
Citation 5 microplate reader at a dual wavelength of 540nm and 595nm. 
Table 8 Standard Concentrations and Dilution Values for DMMB dye Assay 
Working 
Standard (μl) dH2O  (μl) 
Standard 
Amount (μg) 
0 50 0 
5 45 0.25 
10 40 0.5 
20 30 1 
30 20 1.5 
40 10 2 
50 0 2.5 
3.6. Human meniscus harvest and cell isolation 
Knee menisci of human male and females was prepared by the National Disease Research 
Interchange (NDRI) these were sent to us on average two days post death of the individuals. The 
samples were sent on ice in DMEM with antibiotics for preservation of the integrity of the tissue. 
A representative image from one of the samples can be seen in Figure 8. The samples were 
whole menisci as seen in Figure 8, which were dissected to remove excess soft and connective 
tissue. All this as previously mentioned in a sterile environment prepared ahead of time. The 
menisci for the 47-year-old male and female subjects were separated by lateral and medial 
 







menisci. These were then processed for cell isolation following the same protocol performed for 
bovine tissue in section 3.2. With some adjustments as stated in the following section. The tissue 
was treated with 5ml of solution per gram of tissue. The solution was prepared by adding the 
collagenase type 1 (Gibco, Life technologies, 17100-017) into a 50 ml conical tube. This was 
measured as per the required mass to our required volume. The solution was prepared at 10% of 
our final volume to ease the filtration of the solution prior to diluting with Dulbecco’s modified eagle 
medium (DMEM) (Gibco, 11995) with 2% Penicillin-Streptomyosin as an antibiotic. These were 
then placed on an orbital shaker at 2400 RPM (Corning LSE) for 16 hours inside an incubator 
(PHCBi, Panasonic) at 37C with 5% CO2 and 95% humidity. Post digestion with collagenase 2 
the tissue and cell supernatant was then taken and filtered using 60ml syringes with an assembled 
filter with 33um mesh (Spectrum Labs, Cat# 08670203) into a 15 or 50 ml conical tube depending 
on the volume of the solution. The supernatant was centrifuged at 500G for 10 minutes to collect 
the cells at the bottom of the conical tube, the remaining supernatant was removed with an 
aspirating pipette connected a vacuum and waste collector. The cells were suspended in two 
milliliters of media and counted using a hemocytometer (Hausser Scientific) according to 
previously stablished protocols. A 20 μl aliquot of the cell suspension is placed on a piece of 
parafilm and mixed with 20 μl of trypan blue dye (Corning, Lot# 03717004), 10 μl of this solution 
is the loaded on one of the ends of the hemocytometer for cell counting. Once cells are counted 
they are then platted at 2000 cells/cm2. 
3.7. Gene Expression qPCR 
After in-vitro culture and treatment, mRNA was extracted to analyze the effects of estradiol on 
meniscal fibrochondrocytes on extracellular matrix protein markers and estrogen receptor 
markers. The mRNA was extracted with TRIzol reagent (Ambion, Life Technologies, 15596018) 
following the manufacturers protocol. After extraction, mRNA was treated with DNase treatment 
and removal kit (Ambion Life technologies) to eliminate any residual DNA contaminants. Reverse 
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transcription was performed on the mRNA samples to convert to cDNA utilizing the High capacity 
cDNA reverse transcription kit (Applied Biosystems) in RNAse free conditions.  
Human primers used for the experiments included collagen type 1 (Col1a1, Col1a2), collagen 
type 2 (Col2a1), , aggrecan (ACAN), as well as estrogen receptor alpha (ESR1), estrogen 
receptor beta (ESR2), G-coupled estrogen receptor (GPER) and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) as an endogenous control. All of the quantitative PCR analysis was 
done using TAQMAN chemistry assays (Life technologies) using a quantstudio 7 (Thermo Fisher 
Scientific). For the PCR reaction master mix was prepared using 2X Taqman buffer (Life 
technologies), this was then diluted with RNA, DNA free H2O. The total volume was then aliquot 
depending on the repeats of the experiment. Each aliquot would then be added their respective 
primer. Then the solution was mixed by pipetting gently up and down. 20μl of this was then plated 
in a MicroAmp Fast 96 reaction well plate (Themofisher). The plate would then be spun down 
briefly using a centrifuge at 500G for 1 minute to ensure the reaction volume is down and that no 
bubbles were present. A cycle threshold (CT) experiment was then performed for 45 cycles and 
the results were plotted and compared to the GAPDH housekeeping gene as an endogenous 
control with an untreated sample serving as the reference. A list of Primers used during the studies 
is on Table 2. 
3.8. ddPCR Gene Expression 
Similarly, to qPCR once in-vitro culture and treatment was performed, mRNA was extracted to 
analyze the effects of estradiol. The mRNA was extracted as previously discussed in qPCR gene 
expression section. The difference with this approach was the use of BioRad reagents to perform 
the studies. Primers used for these experiments are summarized in Table 2. The PCR plate 
follows the same preparation as in any other PCR reaction, the additional steps for this experiment 
consisted of the following: Briefly, 20μl of the PCR reaction are plated in DG8 cartridges (cat# 
1864008, BioRad) with 70μl of Droplet generation oil for EvaGreen (Cat# 1864006, BioRad). 
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These are then covered with a Droplet generator gasket (Cat# 1863009, BioRad) and placed in 
the QX200 for droplet generation (QX200, BioRad). Once the droplets were formed, the resulting 
emulsion of 40μl was pulled and plated into a fresh 96well plate. The last steps were repeated 
until all samples were prepared. Then the plate was sealed with a pierceable foil and placed in 
the Thermal cycler for 40 cycles at a modified temperature of 105 °C to allow heat transfer with 
the addition of the oil. Once PCR reaction takes place the plate was transferred to a QX200 droplet 
reader for quantification of the gene expression. 
To optimize the concentration of cDNA required to improve on the previous runs of qPCR a 
preliminary study was performed measuring the absolute quantification of the genes in measured 
concentrations of cDNA for the endogenous control and a gene of interest. This was performed 
by first measuring the cDNA content of each sample from lateral meniscus from the pulsed versus 
continuous study. These were measured using 1μl of cDNA loaded onto a Nanodrop 2000 
spectrophotometer. The machine was set to zero by first running two blank samples (DNA, RNA 
free H2O). The values were collected on a spreadsheet and dilutions were performed afterwards. 
These dilutions were in the range of 200, 100, 50, 20, 10, 5, 2, 1, 0 ng/μl. As recommended by 
BioRad the cDNA content per sample run in a ddPCR experiment should not exceed 60ng/ul so 
the experiment tested to 50 ng/μl. 
3.9. Spheroid formation 
Spheroid formation was done by growing meniscal cells to 90% confluence. Cells were counted 
and suspended to a concentration of 2.5 x 106 cells/ml. Spheroids were prepared on a 150mm 
tissue culture petri dish. First, the lid was removed from a 150 mm tissue culture dish and 20 ml 
of PBS was placed in the bottom of the dish. This acted as a hydration chamber. The lid was then 
inverted, and a 20μl multichannel pipetter was used to deposit 20μl droplet onto the lid. Making 
sure that drops were placed apart to not come into contact with each other. Once the droplets 
were placed the lid was flipped onto the PBS-filled bottom chamber and incubated at 37°C/5% 
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CO2/95% humidity. The droplet formation was monitored daily. The cell spheroids took on average 
three days to form. The spheroids were collected using a modified 1ml pipetter tip by aspirating 
the 20ul volume and placed onto a 96 non-adherent well plate. The spheroids then were 
monitored and imaged at day 1 and 7 of treatment. Spheroids were treated with 100 μl of 
treatment solution daily. The treatment conditions included a negative control (noE2) two 
experimental groups low E2 (10-8 M) High E2 (10-6) and a 10ng/ml of TGFB3 as a positive control.  
3.10. Spheroid Imaging 
Spheroids were imaged and monitored at day one and seven. The images were taken with an 
inverted microscope at a 4X magnification. These images were then measured using ImageJ to 
determine their initial size prior to treatment and their size after treatment for 7 days of daily 
dosages. Due to the amorphous nature of the spheroids at the beginning, Feret diameter was 
used as the measurement for analysis. The diameter was measured based on the distance 
between two parallel tangential lines. As seen in the illustration in Figure 9. 
3.11. Statistical Analysis 
Statistical analysis was performed using SPSS and SAS, with these software ANOVA testing was 
performed, while analyzing the effects of media composition and the presence of prfDMEM a 2-
way ANOVA was performed. Similarly when analyzing the data in the effects of estrogen and time 
a 2-way ANOVA was performed. To determine the effects associated with treatment, region and 
 
Figure 9 Feret diameter measurement schematic. Measurements are taken in one plane across two 







time a 3-way ANOVA was carried out. A Tukey Post-Hoc Analysis was performed following the 
ANOVA tests. 
4. Results 
4.1. Effects of Hormone-free FBS composition on meniscal fibrochondrocytes 
During Experiment 1, optimization studies were performed to assess the role of basal media 
components on cell viability and proliferation prior to estrogen dosing studies. In order to 
determine the effect of passaging on MFCs, a visual analysis was performed. Figure 10 has the 
experimental groups in this experiment. Images in Figure 11 display the morphological changes 
Day 1 post plating             Day 3 post plating 
 
Figure 11 Cell morphology of MFCs post plating at P0 and P1, cells were plated at a density of 10,000 






















of the MFCs; these changes could be due to the change in substrate or passaging. The cells in 
the figure were plated at the same initial cell density. Figure 11A and 11B are cells post-harvest 
at days one and three, respectively. By passage one these cells start to quickly adhere and stretch 
in a more spindle-like morphology as seen in Figure 11C and 11D at days one and three, 
respectively. Moving forward an experiment was carried out to determine the effects of media 
composition on MFCs. The groups of the experiment are summarized in Figure 10. To determine 
the effect of charcoal/dextran treated FBS (Char FBS) on proliferation, the meniscus 
fibrochondrocytes treated with media that had 10 % FBS, 10 % Char FBS, or 15 % Char FBS. 
The groups included inner and outer meniscus cell populations. Cells were lysed at one, three, 
and seven days and proliferation determined using the PicoGreen assay as shown in Figure 12. 
Proliferation at day one in both 10 % and 15 % Char FBS was not statistically different from the 
control group. At day three, the control group had a significantly higher cell count compared to 
 
Figure 12 Effect of Char FBS on male bovine MFCs proliferation during Experiment 1.(A) (B) 
PicoGreen assay data showing the proliferation of the inner MFCs over time and with different media 
compositions during two different iterations *p<0.05. (C) (D) PicoGreen Assay data of the outer MFCs 









the experimental groups with the Char FBS. Similarly, at day seven for the inner meniscus the 
control group had a significant difference compared to both groups. The outer meniscus at 15% 
Char FBS did not have a statistically significant difference from the control group. No statistically 
significant changes to total GAG and collagen content were observed due to media composition 
or time as seen in Figure 13. The effect of charcoal FBS and phenol red-free DMEM (prfDMEM) 
on human MFC growth kinetics was determined. The proliferation analysis shows a significant 
difference in cell proliferation as a function of charcoal FBS and prfDMEM in Days 5 and 7-10 
 
Figure 13 Presence of extracellular material in MFCs with different Media compositions during 
Experiment 1. (A)(C) Collagen assay data showing no significant differences or changes in quantity of 
collagen due to time or media composition in either inner or outer meniscus. (B)(D) DMMB assay data 
showing no change in GAG concentration for either time or culture conditions. 
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shown in Figure 14. Overall, prfDMEM significantly reduced cell proliferation compared to cells 
in charcoal FBS and normal FBS medium with doubling times of 4.43 days compared to 2.91 in 
 
Figure 15 LIVE/DEAD Cell viability assay. Representative figures at different media compositions of 
medial meniscus MFCs. Live cells are shown in green and dead cells are shown in red. (A)(B)(C) Inner 
meniscus cells did not have an observable difference in cell viability due to media conditions (C) 
Fluorescence was not detected at 15% Char when imaged but there was a reported value for its 
intensity that did not significantly differ from the other conditions. (D)(E)(F) Outer meniscus cells were 
also not affected in their viability due to media composition during Experiment 1.  Scale bar 400 µm. 
 
Figure 14 Doubling rate of human meniscal fibrochondrocytes with different media and FBS/Char FBS 
concentrations. *p<0.01 +p<0.001. Experiment 1. 
26 
 
charcoal FBS and 3.35 in normal FBS. To determine if the media composition had any negative 
effects on cell viability, a live/dead assay was performed. The results showed no observable 
differences between conditions at 24 and 72 hours from inner and outer menisci. Figure 15 A-C 
are the inner meniscus cells at 72 hours. The pseudo color failed to show in the last image but its 
registered intensity values did not differ significantly from the other two conditions. Figure 15 D-
F are the outer meniscus cell representative images. As observed in the inner meniscus 
fibrochondrocytes, there were no significant differences between treatments.  
A significant difference in the expression of Col1a1 was observed between regions and media 
composition. Figure 16 shows that MFCs in 10% FBS condition experienced a significant 
increase in Col1a1 gene expression, while the 10% Char FBS  treatment resulted in significantly 
lower Col1a1 expression in both inner (IM) and outer meniscus (OM). In addition, the 
fibrochondrocytes from the inner region experienced significantly lower expression of Col1a1 in 
comparison to cells from the outer meniscus when given the same treatment. Col1a1 gene 
transcripts were not detected with cells in 15% Char. Overall, MFCs from OM had a significantly 
larger expression of Col1a1, and both IM and OM had an increased expression in traditional 
 
Figure 16 Gene expression differences of col1a1 in Experiment 1 while treating the meniscus with 






10%FBS compared to 10% Char FBS. The results from the media optimization studies 
determined that 15% Char FBS was adequate for estrogen dosing studies. 
4.2. Effects of estrogen on bovine meniscal fibrochondrocyte proliferation and 
extracellular matrix production 
During Experiment 2 the effect of estrogen on male and female bovine MFC was investigated, 
the experiment design is seen in Figure 17. The effect on proliferation is displayed in Figure 18A 
 
Figure 18  Proliferation, expression of ECM markers, and the presence of extracellular material in male 
and female meniscal fibrochondrocytes with different estradiol treatments for Experiment 2. (A) (B) 
PicoGreen assay data showing the proliferation of the cells over time and with E2 treatment. *p<0.05. 
(C)(D) Quantitative PCR analysis showing relative Gene expression of Col1a1, Col1a2, Col2a1, and 
ACAN in male and female bovine meniscal fibrochondrocytes. (E) (F) DMMB assay data showing no 
change of GAG concentration for either time or E2 treatment conditions. (G)(H) Collagen assay data 












Figure 17 Experimental design for estrogen treatment study (Experiment 2). Male bovine MFC were 
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and 18B. Overall, E2 did not affect proliferation except for male cells at Day three. This effect was 
not observed at seven days. Relative gene expression values are shown in Figure 18C and 18D. 
Both male and female cells experienced a trend of reduced Col1a1 gene expression and an 
increased trend in Col2 and ACAN expression with low estradiol treatment.  In this study, estradiol 
treatment did not significantly affect total GAG (Figure 18E and 18F) or collagen content (Figure 
18G and 18H). In all of the analysis, there was evidence that estradiol exhibited dose-dependent 
effects. However, due to small sample sizes, the data was not statistically significant.  
4.3. Effects of estrogen on human meniscal fibrochondrocyte proliferation and 
extracellular matrix production 
During Experiments 1 and 2 studies were performed using bovine meniscal cells to optimize the 
parameters for treatment of human meniscal cells. Using the optimized media conditions, 
estrogen-dosing studies were then conducted as part of our Experiment 3 on human male and 
female MFCs harvested from the tissue of 47-year old patients. In order to compare the effects of 
E2 treatment at pulsed versus continuous dosing, the MFCs were exposed to the same total 
 
Figure 19 Dosage scheme for pulsed versus continuous treatment of MFCs. Experimental design for 
Experiment 3, human MFCs were treated with different dosages and kinetics as seen at the bottom 
of the figure. Grey lines represent the pulsed treatment, black line represents the continuous 
treatment. Treatment was administered during the first hour and removed, replenishing with the 
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amount of E2, either provided as a 1-hour dosage or administered continuously for 24 hours. The 
treatment was performed at concentrations where a significant response was previously 
observed. A schematic of the dosage and treatment groups and parameters is displayed in Figure 
19. At 24 hours, male LM cells treated with E2 experience a significant increase in cell proliferation 
when compared to the No E2 group as seen in Figure 20. This was not observed at the medial 
meniscus or at the same time with female samples. At 48 hours, pulsed high condition elicited a 
significant difference in male medial meniscus. Meanwhile the pulsed high E2 condition elicited a 
significantly higher response than other treatment groups for female cell samples. At 24 and 48 
hours, male samples of all treatment groups had a significant difference when compared to female 
samples where the male cells had a larger cell proliferation.  
Gene expression was determined by performing quantitative polymerase chain reaction (qPCR). 
No significant differences were observed in the gene expression of matrix macromolecules 
 
Figure 20 Proliferation over time of MFC with different dosage kinetics for Experiment 3. Male MFCs 
experienced a significant increase in proliferation at 24 hours shown in the right side *p<0.05. Female 







comparing male and female lateral meniscus at 24 hours of treatment. Figure 21 shows the gene 
expression of ACAN, and Col1a1, which did not experience a significant increase with treatment. 
Col2, ESR1, ESR2, and GPER failed to amplify during qPCR. Due to low amplicon levels, droplet 
digital PCR (ddPCR) was used. To optimize the ddPCR reaction due to its high sensitivity and 
the recommendations of the supplier (BioRad), a study was performed using the endogenous 
 









Figure 21 Gene expression profile of MFCs after treatment with E2 during Experiment 3 at different 
dosage kinetics. Relative expression data demonstrated no significant differences due to treatment or 







control (GAPDH) as well as Col2 to determine the appropriate cDNA concentration to use to 
observe a reading without having a large cluster of positive results. Both runs had a linear growth 
with increased cDNA concentration. The standard curve is shown in Figure 22. Figure 23 and 
Figure 24 illustrate ddPCR results for 24 and 48 hours, respectively. There were no observed 
 
Figure 24 Gene expression profile of MFCs after treatment for 48 hours of E2 at high (10-8M) and low 






Figure 23 Gene expression profile of MFCs after 24 hour treatment with E2 at high (10-8M) and low 







significant differences between sex and treatment in the combined regions of the lateral meniscus 
samples from both 24 and 48 hours.  
4.4. Regional separation of young male meniscus  
 
Experiment 4 was carried out to determine if there were regional differences in proliferation with 
estrogen treatment. The cell isolation was performed per region of the meniscus in a male sample 
(18 years old) as seen in Figure 25(A-C), the cells post isolation were then treated with the 
dosages noted in 25D. Cells from both the medial and lateral disc were combined. The groups for 
this experiment are summarized in Figure 25 D. Proliferation of the initial run did not have 
statistically significant differences due to treatment within regions except for day 1 where the no 
E2 was significantly larger than the pulsed and continuous treatment groups in the inner region 
during the initial run. Differences were significant when groups were compared per region.  A 
second run of the experiment was performed to evaluate reproducibility. As the outer and middle 
regions of the meniscus did not have a significant difference in the initial study, the repeat study 
 
Figure 25 Regional separation of the meniscus. (A) Meniscus as received from NDRI. (B) Meniscus 
after fine dissection was performed. (C) Meniscus separated by regions. (D) Study treatment 




was only conducted with inner and outer fibrochondrocytes. During this run, the cells did not 
experience a significant increase as seen in the right side of Figure 26. 
4.5. Spheroid formation 
 
Figure 26 Proliferation of young adult human male (18 years) MFCs in Experiment 4 separated per 
region and treated with NoE2 (0M) pulsed (24*10-8 M) and continuous dosages (10-8M) of Estrogen. On 






Figure 27 Preparation of MFCs scaffoldless 3D culture model. Human MFCs were isolated and cultured 
to P2. They were formed over a 3-day period using hang-drop method at 50,000 cells and treated with 




To determine the effects of E2 treatment in 3D cell culture, a pilot study Experiment 5 was carried 
using spheroids formed at a density of 50,000 cells and treated with No E2, Low E2, High E2, or 
TGF-β3 as shown in Figure 27. The spheroids were imaged at days 1 and 7 of treatment and 
measured using ImageJ. Representative images are shown in Figure 28 and an analysis in the 
 
Figure 28 Spheroids from human male MFCs (18 years) formed at cell density of 50K cells. Inner and 
outer meniscus spheroids experience a significant decrease in size from fabrication (day 1) to last day 
of treatment. Low E2 in the inner meniscus experience a significantly lower decrease in size.    





Figure 29 Percentage reduction of spheroids in different culture media in Experiment 5. Overall, the 
outer meniscus spheroids in the Low E2 treatment group experience a significantly lower decrease in 




decrease of Feret Diameter is shown in Figure 29. The averages of the spheroid sizes is as well 
as the changes observed are summarized in Table 9. This information provided a visual means 
to determine potential effects of the treatment. Size differences due to time were significantly 
different, and a significant difference due to treatment was observed in the LowE2 treatment group 
compared to No E2 in the outer meniscus spheroids while the inner meniscus spheroids had the 
LowE2 group significantly different to the HighE2 group. Spheroids of inner meniscus had an 
initial size larger than that of outer meniscus spheroids, but the size change was not significantly 
different between regions when compared as a whole. The differences due to treatment provide 
focus for future studies. 
Table 9 Spheroid sizes through experiment 
Region Treatment Day 1 average 
(μm) 
Day 7 average 
(μm) 
 Percent size Δ 
(%) 
Outer No E2 370 +/- 65 245 +/- 12 32.7 +/- 9.9 
Outer Low E2 361 +/- 12 287 +/- 10 20.5 +/- 0.4 (*) 
Outer High E2 361 +/- 12 276 +/- 21 23.6 +/- 6.7 
Outer TGFB3 394 +/- 10 298 +/- 6 24.3 +/- 3.2 
Inner No E2 414 +/- 18 323 +/- 15 21.9 +/- 2.8 
Inner Low E2 417 +/- 20 344 +/- 2 17.4 +/- 4 (+) 
Inner High E2 429 +/- 12 316 +/- 8 26.5 +/- 1.7 
Inner TGFB3 407 +/- 12 315 +/- 3 22.4 +/- 3.1 
 
5. Discussion 
Through these experiments, the goal of our studies was to establish a platform for assessment of 
estrogens effects on the knee meniscus fibrochondrocytes. The effect of media composition, 
estrogen dosing and kinetics, 2D vs 3D culture were determined. Overall, E2 treatment did not 
36 
 
have a significant effect on the proliferation of female cells from bovine and human tissues, and 
the upregulation of ECM genes was observed to be upregulated with no significant differences. 
GAG and collagen production was not significantly different due to treatment or sex as seen in A 
Table 10 were the overall findings of this thesis are summarized. Overall media composition had 
a significant effect on proliferation of MFCs, and there were trends that alluded to the effect of 
estrogen preserving the avascular phenotype of the MFCs in females but not in male MFCs. This 
was not what had been initially hypothesized. 
Table 10 Estrogen effects on meniscal fibrochondrocytes (↓ decrease, ↑ increase, ↔ no change, N/A not 
tested yet) 
Species Tissue Gender Age Region Proliferation GAG Collagen Gene 
Expression 













































Whole ↔ N/A N/A ↔ Col1a1 
↑ Col2a1 
↑ Acan 





Inner ↔ N/A N/A N/A 
Middle ↔ N/A N/A N/A 




Male 18 Inner N/A N/A N/A N/A 
Outer N/A N/A N/A N/A 
  
5.1. Effects of media composition on MFCs 
Prior to estrogen dosing studies, it was critical to determine the effects of hormone-free media 
components on meniscal fibrochondrocytes(Welshons, Wolf, Murphy, & Jordan, 1988). In these 
studies, there was a different response due to region. Specifically due to media change between 
inner and outer menisci. This could be due to the differences in cell composition of the meniscus 
as others have noted the heterogeneity of the tissue cell population. It has been previously 
reported that the cells experience a doubling rate of .4X every day (Liang et al., 2017) contrasting 
the reported findings of this thesis in which cells doubled at a slower rate. These differences are 
likely due to media composition, and it was predicted to play a significant role in the proliferation 
of MFCs. 




Estradiol treatment plays a role in maintenance of the fibrocartilaginous tissue. A study conducted 
by Robinson et.al has shown that exposure to estrogen in ovariectomized mice stimulated 
chondrogenesis and inhibited protease activity in temporomandibular fibrocartilage(Robinson et 
al., 2018). Additionally, it has been observed in a study done by Ham et al. in 2002 that the long-
term use of estrogen can be used to slow the development of osteoarthritic lesions in the knee 
meniscus of primates.(Ham, Loeser, Lindgren, & Carlson, 2002) These animal models suggest 
that the sex hormone estrogen plays a role in maintaining the health and homeostasis of the 
meniscus. In this study, expression of Col1a1 decreased and expression of Col2a1 and ACAN 
increased in response to treatment. This is important as this could indicate potential regenerative 
properties of E2 in the avascular region of the meniscus. Similar findings were observed in murine 
growth plate chondrocytes at an intermediate dose of 17β-estradiol, further supporting the results 
of this study (Schwartz, 2013).  
In general, studies in the literature show an increase in proliferation in female cells in response to 
E2 at the concentrations investigated in Experiment 2. This was not the case during the study. 
No significant differences were observed due to treatment in regards to proliferation and matrix 
production. In a rabbit animal model it was observed that the treatment of the knee meniscus with 
estrogen did not significantly have an effect in the degradation of GAG or collagen while other 
fibrocartilaginous tissues were(Hashem et al., 2006). Validating the current findings of this thesis, 
which indicates that these cells are likely not the target for treatment with estrogen to induce the 
repair of meniscal injuries. These events could be due to the lower expression and presence of 
estrogen receptors in the meniscus compared to other fibrocartilaginous tissues like the pubic 
symphysis and temporomandibular joint disc(W. Wang et al., 2009). While we saw, an increase in 
proliferation during Experiment 2 this same effect was not detected through the remainder of the 
experiments when MFCs were treated with continuous dosage of the same concentration of E2 
of 10-8M. One potential reason for this effect is the relative levels of ERα in these cells was below 
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a level to be detected as seen in Experiment 3 where only the female control group at 48 hours 
of treatment expressed some relative presence of ERα. Subsequent studies should look at the 
presence of ERβ as it has been shown in other fibrocartilaginous tissues to promote opposite 
effects to ERα(Ahmad, Chen, Wang, & Kapila, 2018). A summary to the effects observed through 
the experiments performed for this thesis are listed in Table 10.  
The change of environment and short time in culture on a hard substrate could be the cause for 
low levels of total GAG and collagen observed, as it has been reported that MFCs, which possess  
fibroblastic and chondrogenic characteristics, exhibit phenotypic changes as they are 
passaged(Gunja & Athanasiou, 2007). These changes could elicit a lower production of the 
extracellular matrix macromolecules. We determined that, although no statistically significant 
changes were reported in proliferation or gene expression in both human and bovine, distinct 
changes were observed in male and female samples. For low E2, the expression of ACAN and 
Col2a1 changed from a few reported at 24 hours of treatment to every sample reporting at 48 
hours, suggesting an upregulation of ACAN and Col2a1 while downregulating Col1a1Similarly, 
male samples expressed Col1a1 prominently at 24 hours in the low E2 treatment but decreased 
to almost zero by 48 hours. This could hint at the potential effects of 17β-estradiol to lead these 
cells to a more avascular meniscus phenotype. 
In Experiment 3, it was observed that sex played a significant role in the proliferation of human 
MFCs of the same age. Male samples experienced an increase in proliferation, but they also had 
a higher expression of Col1a1. These findings suggest differences in response to estrogen 
treatment based on sex. This is different from other reports where it was observed that treatment 
of chondrocytes at similar conditions to the experiments in this thesis, demonstrated that female 
cells had a significant increase in proliferation compared to male chondrocytes (Chang, Kuo, Lin, 
& Yang, 2014; Hashem et al., 2006) in a rabbit model. Similarly, in costochondral cartilage it is 
observed  that a difference in membrane estrogen receptors is the reason to the dimorphic 
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response to estrogen treatment(Elbaradie et al., 2013). Both of these studies ultimately point to 
differences in response due to sex. Another study performed by Brophy et al. showed distinct 
responses to trauma based on sex and age of the patients(Brophy, Rai, Zhang, Torgomyan, & 
Sandell, 2012). In this study, it was observed that the expression of inflammation markers was 
significantly higher in subjects under the age of 40. This indicates an increased catabolic response 
which can increase the degradation of the meniscus(Brophy et al., 2012). Overall, the results 
observed in the current studies of this thesis have similar responses in ECM formation. The 
differences observed due to sex is particularly different to the current understanding of E2 and 
MFCs in males and should be explored further particularly in the events of quiescence and 
apoptosis as these metabolic processes could elucidate further whether estrogen is acting as an 
arrestor in MFCs proliferation.  
5.3. Understanding the effects of estrogen treatment in the meniscus at different regions 
Understanding the cellular composition of the meniscus can help develop targeted treatments for 
the local environment. The meniscus is composed of a heterogeneous population of cells 
comparable to articular cartilage cells and fibroblast-like cells(Nakano, Dodd, & Scott, 1997). 
Recently, more studies have been aimed at defining the genetic markers associated to the regions 
of the meniscus in order to provide design criteria for the tissue engineering of the 
meniscus(Grogan, Pauli, Lotz, & D’Lima, 2017; Verdonk et al., 2005). The meniscus cells from 
vascular and avascular regions of the meniscus resemble those of hyaline cartilage(Grogan et 
al., 2017). Between these two regions, distinct markers that can help determine the population of 
the cells were found(Grogan et al., 2017; Verdonk et al., 2005). The outer meniscus has a higher 
incidence of CD90-positive cells, which is consistent with a more fibroblast-like phenotype. It has 
been reported that in the inner region of the meniscus the presence of Col2a1 and Acan make up 
the bulk of its ECM while the outer region of the meniscus expresses Col1a1 at a higher incidence  
(Verdonk et al., 2005). Both of these regions produced a higher amount of Col1a1 when compared 
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to articular chondrocytes(Nakano et al., 1997). This profile can be used in future studies to 
categorize the cell population in the meniscus. 
There are mixed reviews regarding the plasticity of meniscal fibrochondrocytes and their ability to 
differentiate. There is evidence to support that, with optimized culture medium and appropriate 
cues, these cells have both chondrogenic and adipogenic differentiation potential (Cui, 
Hasegawa, Lotz, & D’Lima, 2012; Liang et al., 2017; Mauck, Martinez‐Diaz, Yuan, & Tuan, 2007). 
Studies performed using MFCs of the inner and outer meniscus have both been shown to 
differentiate under hypoxic conditions with the addition of TGF-β3 to a chondrogenic 
phenotype(Liang et al., 2017) and, more importantly, that they were able to generate tissues with 
the functional matrix characteristics of avascular meniscus. Similarly, a study by Cui showed that 
a co-culture model with varying ratios of MFCs and mesenchymal stem cells (MSCs) was able to 
generate meniscus tissue constructs.  
5.4. Importance of 3D Culture of MFCs 
Since the early 1990s 3D culture studies have been performed demonstrating the importance to 
provide cells with an environment more like their native structure(B. M. Baker et al., 2015; Bao et 
al., 2018; Bhattarai, Aguilar, Park, & Kim, 2018; Cameron, Frith, & Cooper-White, 2011; Das, 
Gocheva, Hammink, Zouani, & Rowan, 2016; Elson & Genin, 2016; Galbraith & Sheetz, 1998; 
Gao, Peng, Feng, & Shuai, 2017; Gong et al., 2018; Papalazarou, Salmeron-Sanchez, & 
Machesky, 2018; Tan et al., 2013).  In these studies, the cellular responses to their material 
surrounding played a significant role in expressed genes, as well as their potential to repair and 
remodel the ECM. We wanted to develop a 3D culture system that would allow cell expansion 
that more closely resembles those in vivo conditions. This was attempted since others have 
shown that the change in phenotype can be moderately reduced when these cells are cultured in 
3D(Son & Levenston, 2017). To perform this we exploited the ability of meniscus cells to form 
small cell aggregates when forced together in hanging drops. The cells were suspended and the 
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cell aggregates formed within 3 days. Others have found that the use of a scaffold free 
environment when given the appropriate cues develop micro tissues that closely resemble those 
found in vivo(Klingelhutz et al., 2018). The size changes that occurred during the culture of these 
spheroids could be due to the media composition used for this experiment as the cells are 
experiencing a different environment in comparison to the previous experiments in monolayer 
culture. Kingelhultz et al performed a study with adipocytes using differentiating media and non-
differentiating media where they saw that the spheroids in differentiating media grew through the 
length of the study while the volume decrease in the other condition. This is similar to what we 
observed in the meniscal fibrochondrocytes, which could be indicative that the effect of estrogen 
is not significantly aiding, but it is also not playing a detrimental role. To be able to determine more 
thoroughly the effects, subsequent studies analyzing the proliferation as well as ECM protein 
composition are necessary. Similarly as estrogen has been observed to induce apoptosis and 
enhancement of matrix biosynthesis in other fibrocartilage cells(H. Wang et al., 2014; Yang et al., 
2018) determining the role of estrogen treatment in these cellular events in 3D culture of MFCs 
could provide valuable information.  
6. Limitations 
While the models and results produced in this thesis work provide a sound foundation for future 
studies, it is understood that every study has limitations. The fact that prfDMEM inhibited 
proliferation over time suggests that this media condition may promote cell quiescence. This 
change in cell cycle behavior could play a role in the response to estrogen observed in the 
presented in vitro studies. Variability between human subjects is another limitation in this study. 
Variability in biological systems encompasses differences from environmental factors to genetic 
differences, adding more nuance to determining effects for a global population based on three 
subjects (Wall et al., 2014; Zeise et al., 2013). The age of our subjects could have a significant 
role in the differentiation potential of the meniscal fibrochondrocytes it was shown that the effect 
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of estradiol does not play a significant role on jaw fibrochondrogenesis in mature mice(Robinson 
et al., 2018) . The estrogen treatment conditions for the studies presented in this thesis only 
included five concentrations, additional concentrations should be included in future studies to 
determine the cell response to treatment and to rule out any dosage dependency on the cells in 
question. The time points of collection in Experiment 3 and 4 should be expanded to determine 
the effects of dosage over time as an upregulation of ECM markers was observed to increase 
with time. Similarly a prolonged study in 3D culture should be performed to expand on the effects 
of estrogen in scaffoldless culture conditions as others usually treat for 21-28 days(Klingelhutz et 
al., 2018).   
7. Conclusions and Future Directions 
Development of 2D and 3D platforms for analysis of estrogen activity in the meniscus have been 
established in this thesis work. We hypothesized that the change from fully supplemented FBS to 
Char FBS would not affect the MFCs proliferation of significantly. What we observed was that 
hormone-free media components significantly affect fibrochondrocyte proliferation. In particular, 
the use of phenol red free DMEM can have a detrimental effect on the proliferation of meniscal 
fibrochondrocytes in human as well as bovine cells.  Our hypothesis was that estrogen treatment 
would promote cell proliferation and ECM gene and protein production. E2 promotes the 
upregulation of ACAN and Col2a1 gene expression while decreasing Col1a1 expression, at 
concentrations of 10-8M. Further, in the spheroid culture model, 10-8M E2 decreased significantly 
less in diameter compared to the 0M E2 group. In part, our hypothesis that E2 would promote the 
upregulation of ECM proteins was partially validated, but the proliferation of cells was not. The 
experimental findings in this thesis supported by other findings indicate that the MFCs are likely 
not the primary target for E2 treatment in the pursuit of meniscus tissue regeneration. Current 
studies are focused on determining the role of estrogen on synovium progenitor cells, as these 
cells are known to regulate remodeling in the knee joint and likely play a role on new meniscus 
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tissue growth. These findings will continue to be explored to expand on our working knowledge 
and develop better strategies to probe the effects of E2 on other cells in the knee joint and 
determine their role in knee health and joint tissue homeostasis. As the knee joint is composed of 
multiple tissues co-culture models utilizing the findings of this work shall be developed to 
determine the individual role of chondrocytes, synovium derived progenitor cells, and MFCs as 
well as their crosstalk in the tissue homeostasis of the joint. Similarly, future studies will 
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